초록 열기/닫기 버튼

A biodegradable stent is a novel concept designed to prevent restenosis within blood vessels over six months, ultimately being completely absorbed within 3-5 years. In other words, biodegradable stents aim to address acute occlusion caused by intimal damage and detachment that often occurs after balloon dilation. They also seek to prevent negative remodeling by maintaining the inner diameter of the blood vessel for approximately six months and possess antiproliferative properties. The controlled release of a drug helps prevent excessive intimal growth and the subsequent occurrence of restenosis. Ongoing research is focused on developing biodegradable stents with thinner strut thicknesses, potentially allowing them to re-enter the market. Consequently, large-scale clinical trials for more advanced biodegradable stents are imperative to build upon existing studies and address reported side effects and risks, which may have arisen due to small reference diameters and misalignment of positions. Additionally, meticulous device optimization techniques, including intravascular imaging, are essential to mitigate potential side effects and risks associated with biodegradable stents. This study aims to analyze the side effects of Drug-Eluting Stents (DES) used for vascular diseases, explore current trends in clinical research related to biodegradable stents, and discuss the potential clinical applications of these innovative medical devices.